Published in Biol Psychiatry on January 01, 1991
Trace amine-associated receptor 1-Family archetype or iconoclast? Pharmacol Ther (2007) 1.72
Neurogenetics and Nutrigenomics of Neuro-Nutrient Therapy for Reward Deficiency Syndrome (RDS): Clinical Ramifications as a Function of Molecular Neurobiological Mechanisms. J Addict Res Ther (2012) 1.19
β-Phenylethylamine requires the dopamine transporter to increase extracellular dopamine in Caenorhabditis elegans dopaminergic neurons. Neurochem Int (2013) 0.86
Tetramethylpyrazine analogue CXC195 protects against cerebral ischemia/reperfusion-induced apoptosis through PI3K/Akt/GSK3β pathway in rats. Neurochem Int (2014) 0.83
Trace Amines and the Trace Amine-Associated Receptor 1: Pharmacology, Neurochemistry, and Clinical Implications. Front Neurosci (2016) 0.81
β-phenylethylamine, a small molecule with a large impact. Webmedcentral (2013) 0.77
No Tryptophan, Tyrosine and Phenylalanine Abnormalities in Children with Attention-Deficit/Hyperactivity Disorder. PLoS One (2016) 0.75
Studies leading to the identification of ZD1839 (IRESSA): an orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor targeted to the treatment of cancer. Bioorg Med Chem Lett (2001) 2.86
Does hair zinc predict amphetamine improvement of ADD/hyperactivity? Int J Neurosci (1990) 1.46
Screening for cognitive dysfunction in multiple sclerosis. Arch Neurol (1996) 1.44
Estimated premorbid intelligence mediates neurobehavioral change in individuals infected with HIV across 12 months. J Clin Exp Neuropsychol (2000) 1.32
Neuropsychological correlates of negative, disorganized and psychotic symptoms in schizophrenia. Schizophr Res (1998) 1.32
Practice effects on commonly used measures of executive function across twelve months. Clin Neuropsychol (1999) 1.32
Tumour dose response to the antivascular agent ZD6126 assessed by magnetic resonance imaging. Br J Cancer (2003) 1.23
Cognitive impairment and cerebral structure by MRI in bipolar disorder. Biol Psychiatry (1990) 1.19
Metabolism of amphetamines. Identification of N-oxygenated products by gas chromatography and mass spectrometry. J Pharm Pharmacol (1973) 1.10
Psychopathology in human immunodeficiency virus infection: lifetime and current assessment. Compr Psychiatry (1993) 1.06
Relative memory deficits in recurrent versus first-episode major depression on a word-list learning task. Neuropsychology (1999) 1.02
Neuropsychological changes following carotid endarterectomy. Can J Neurol Sci (1981) 1.01
Involvement of CYP3A4 and CYP2D6 in the metabolism of haloperidol. Cell Mol Neurobiol (1997) 1.01
Synthesis of N-propargylphenelzine and analogues as neuroprotective agents. Bioorg Med Chem Lett (2001) 0.97
Involvement of CYP2D6 in the in vitro metabolism of amphetamine, two N-alkylamphetamines and their 4-methoxylated derivatives. Xenobiotica (1999) 0.94
Neuropsychological abnormalities in Gilles de la Tourette's syndrome. J Nerv Ment Dis (1983) 0.94
Consistency of intermanual discrepancies in normal and unilateral brain lesion patients. J Consult Clin Psychol (1986) 0.92
Effects of intravenous lipid as a source of energy in parenteral nutrition associated hepatic dysfunction and lidocaine elimination: a study using isolated rat liver perfusion. Biopharm Drug Dispos (1997) 0.92
Insights into the mechanisms of action of the MAO inhibitors phenelzine and tranylcypromine: a review. J Psychiatry Neurosci (1992) 0.91
Neurobehavioural consequences of substance abuse and HIV infection. J Psychopharmacol (2000) 0.91
Failed suicide attempt by emission gas poisoning. Am J Psychiatry (1984) 0.90
Metabolic drug interactions with selective serotonin reuptake inhibitor (SSRI) antidepressants. Neurosci Biobehav Rev (1998) 0.88
Normative data on intermanual differences on three tests of motor performance. J Clin Exp Neuropsychol (1986) 0.87
Practice effects on the Wisconsin Card Sorting Test-64 Card version across 12 months. Clin Neuropsychol (2001) 0.87
Pharmacokinetics of ibuprofen enantiomers in humans following oral administration of tablets with different absorption rates. Pharm Res (1988) 0.87
Asymmetrical cognitive differences associated with hemiparkinsonism. Arch Clin Neuropsychol (1992) 0.87
Comparison of chemical components and antioxidants capacity of different Echinacea species. J Pharm Pharmacol (2001) 0.86
Differences between IQ and school achievement in anorexia nervosa. J Clin Psychol (1989) 0.86
Neuropsychological deficits in psychotic versus nonpsychotic unipolar depression. Neuropsychology (1999) 0.86
Simultaneous determination of fluoxetine and norfluoxetine enantiomers in biological samples by gas chromatography with electron-capture detection. J Chromatogr (1992) 0.85
Determination of paroxetine levels in human plasma using gas chromatography with electron-capture detection. J Chromatogr B Biomed Sci Appl (2000) 0.84
Identification of kaempferol as a monoamine oxidase inhibitor and potential Neuroprotectant in extracts of Ginkgo biloba leaves. J Pharm Pharmacol (2000) 0.83
Neuropsychological performance and CD4 levels in HIV-1 asymptomatic infection. J Clin Exp Neuropsychol (1994) 0.83
Effects of immunosuppression and disease severity upon neuropsychological function in HIV infection. J Clin Exp Neuropsychol (2000) 0.83
Stereoselective gas chromatographic analysis of etodolac enantiomers in human plasma and urine. J Chromatogr (1986) 0.83
Wechsler VIQ versus PIQ differences in cerebral dysfunction: a literature review with emphasis on sex differences. J Clin Neuropsychol (1982) 0.83
Metabolism of some "second"- and "fourth"-generation antidepressants: iprindole, viloxazine, bupropion, mianserin, maprotiline, trazodone, nefazodone, and venlafaxine. Cell Mol Neurobiol (1999) 0.83
Elucidation of individual cytochrome P450 enzymes involved in the metabolism of clozapine. Naunyn Schmiedebergs Arch Pharmacol (1998) 0.82
Dose-response relationship of doxapram in the therapy for refractory idiopathic apnea of prematurity. Pediatrics (1987) 0.82
The antidepressant drug phenelzine produces antianxiety effects in the plus-maze and increases in rat brain GABA. Psychopharmacology (Berl) (1996) 0.82
Interactions of iprindole with fenfluramine metabolism in rat brain and liver. J Psychiatry Neurosci (1991) 0.82
Cognitive deficits distinguish patients with adolescent- and adult-onset schizophrenia. Neuropsychiatry Neuropsychol Behav Neurol (1997) 0.82
Depression accounts for executive function deficits in obsessive-compulsive disorder. Neuropsychiatry Neuropsychol Behav Neurol (2001) 0.82
Effects of the antidepressant phenelzine on brain levels of gamma-aminobutyric acid (GABA). J Affect Disord (1991) 0.82
Doxapram dosage regimen in apnea of prematurity based on pharmacokinetic data. Dev Pharmacol Ther (1988) 0.80
A factor analytic study of the construct validity of the verbal concept attainment test. J Clin Neuropsychol (1982) 0.80
Relationship of age to neuropsychological deficit in Tourette's syndrome. J Dev Behav Pediatr (1985) 0.80
Chemical and pharmacological evaluation of Hypericum perforatum extracts. Acta Pharmacol Sin (2000) 0.80
Metabolism in vitro of N-methylamphetamine with rat liver homogenates. Biochem Pharmacol (1977) 0.80
Neuropsychological correlates of learning disability subtypes in children with Tourette's syndrome. J Int Neuropsychol Soc (1996) 0.80
Urinary excretion of phenolic metabolites of N-(n-propyl)amphetamine in man. Res Commun Chem Pathol Pharmacol (1977) 0.80
Fungal metabolism of (-)-deprenyl and pargyline. Life Sci (1981) 0.79
Chronic administration of the antidepressant-antipanic drug phenelzine and its N-acetylated analogue: effects on monoamine oxidase, biogenic amines, and alpha 2-adrenoreceptor function. J Pharm Sci (1992) 0.79
In vitro metabolism of 1-phenyl-2-(n-propylamino) propane (N-propylamphetamine) by rat liver homogenates. J Pharm Pharmacol (1976) 0.79
Metabolism and disposition of N-(2-cyanoethyl)amphetamine (fenproporex) and amphetamine: study in the rat brain. Can J Physiol Pharmacol (1986) 0.79
Determination of p-trifluoromethylphenol, a metabolite of fluoxetine, in tissues and body fluids using an electron-capture gas chromatographic procedure. J Chromatogr B Biomed Sci Appl (1997) 0.79
Acetylation and pentafluorobenzoylation of lidocaine metabolites in aqueous solution and identification of derivatives by combined gas chromatography/mass spectrometry. Biomed Environ Mass Spectrom (1987) 0.79
N-(2-cyanoethyl)tranylcypromine, a potential prodrug of tranylcypromine: its disposition and interaction with catecholamine neurotransmitters in brain. Pharm Res (1987) 0.79
In vivo phenolic metabolites of N-alkylamphetamines in the rat. Evidence in favor of catechol formation. Drug Metab Dispos (1976) 0.79
Limited accuracy of premorbid intelligence estimators: a demonstration of regression to the mean. Clin Neuropsychol (2000) 0.79
Liposomal encapsulation enhances the antitumour efficacy of the vascular disrupting agent ZD6126 in murine B16.F10 melanoma. Br J Cancer (2008) 0.78
Failure to detect amphetamine or 1-amino-3-phenylpropane in humans or rats receiving the MAO inhibitor tranylcypromine. J Affect Disord (2000) 0.78
Effects of localized lesions on the Verbal Concept Attainment Test. J Clin Exp Neuropsychol (1985) 0.78
Neuropharmacological and neurochemical properties of N-(2-cyanoethyl)-2-phenylethylamine, a prodrug of 2-phenylethylamine. Br J Pharmacol (1987) 0.78
Unilateral lesions and the Wechsler Adult Intelligence Scale-Revised: no sex differences. J Consult Clin Psychol (1984) 0.78
Recent studies on the MAO inhibitor phenelzine and its possible metabolites. J Neural Transm Suppl (1990) 0.78
Neuropsychological and electrophysiological examination of a patient with Wilson's disease. Int J Neurosci (1985) 0.78
N2-acetylphenelzine: effects on rat brain GABA, alanine and biogenic amines. Naunyn Schmiedebergs Arch Pharmacol (1991) 0.78
Synthesis and pharmacological evaluation of some , -disubstituted analogs of acetylcholine. J Med Chem (1972) 0.78
Metabolic acetylation of phenelzine in rats. Res Commun Chem Pathol Pharmacol (1988) 0.78
Electron-capture gas chromatographic analysis of beta-phenylethylamine in tissues and body fluids using pentafluorobenzenesulfonyl chloride for derivatization. J Chromatogr (1986) 0.78
N-(3-chloropropyl)phenylethylamine as a possible prodrug of beta-phenylethylamine: studies in the rat brain. Prog Neuropsychopharmacol Biol Psychiatry (1987) 0.77
Analysis of imipramine and three metabolites produced by isozyme CYP2D6 expressed in a human cell line. Xenobiotica (1993) 0.77
N,N-dipropargyl-2-phenylethylamine, a potential prodrug of 2-phenylethylamine: neurochemical and neuropharmacological studies in rat. Brain Res Bull (1987) 0.77
Effects of intravenous infusion of lidocaine on its pharmacokinetics in conscious instrumented dogs. J Pharm Sci (1997) 0.77
Adverse drug reactions and debrisoquine/sparteine (P450IID6) polymorphism in patients with fibromyalgia. Clin Rheumatol (1997) 0.77
Self-report of symptoms and neuropsychological performance in asymptomatic HIV-positive individuals. J Neuropsychiatry Clin Neurosci (1994) 0.77
A gas chromatographic procedure for separation and quantitation of the enantiomers of the antidepressant tranylcypromine. Biochem Pharmacol (1992) 0.77
Long-lasting elevation of alanine in brain produced by the antidepressant phenelzine. Brain Res Bull (1990) 0.77
Effects of chronic benzodiazepine administration on neuropsychological performance. Clin Neuropharmacol (1985) 0.77
Classification rates obtained with "standard" cut-off scores on selected neuropsychological measures. J Clin Exp Neuropsychol (1986) 0.77
Central nervous system involvement in the eosinophilia-myalgia syndrome. Arch Neurol (1992) 0.77
Neurochemical and metabolic aspects of antidepressants: an overview. J Psychiatry Neurosci (2000) 0.77
Lack of a pharmacokinetic interaction between doxapram and theophylline in apnea of prematurity. Dev Pharmacol Ther (1991) 0.77
Urinary excretion of MHPG and normetanephrine in attention deficit hyperactivity disorder. Mol Chem Neuropathol (1993) 0.77
A rapid electron-capture gas chromatographic method for the quantification of fluvoxamine in brain tissue. J Pharmacol Toxicol Methods (1997) 0.76
A comparison of the neurochemical properties of the stereoisomers of tranylcypromine in the central nervous system. Cell Mol Biol (1986) 0.76
Construct validity of the Knox Cube Test as a neuropsychological measure. J Clin Neuropsychol (1983) 0.76
Pentafluorobenzenesulfonyl chloride as a sensitive reagent for the rapid gas chromatographic analysis of tranylcypromine in tissues and body fluids. Biochem Pharmacol (1986) 0.76
Relationship of age and education to neuropsychological performance in patients with symptomatic carotid artery disease. J Clin Psychol (1983) 0.76
A method for measurement of tranylcypromine in rat brain regions using gas chromatography with electron capture detection. Biochem Pharmacol (1981) 0.76
Metabolism of N,N-dialkylated amphetamines, including deprenyl, by CYP2D6 expressed in a human cell line. Xenobiotica (2000) 0.76
Patterns of obsessive compulsive symptoms in Tourette subjects are independent of severity. Anxiety (1997) 0.76
Determination of 4-(4-chlorophenyl)-4-hydroxypiperidine, a metabolite of haloperidol, by gas chromatography with electron-capture detection. J Chromatogr B Biomed Appl (1996) 0.76
Effects of taurine supplementation in parenteral nutrition-associated hepatosteatosis and lidocaine metabolism. A study using isolated rat liver perfusion. Drug Metab Dispos (1996) 0.76
Effects of acute and chronic administration of phenelzine on 2-phenylethylamine levels in rat brain. Proc West Pharmacol Soc (1982) 0.76
Human CYP2D6 and metabolism of m-chlorophenylpiperazine. Biol Psychiatry (1998) 0.76
Analysis of amines in the central nervous system by gas chromatography with electron-capture detection. Prog Neurobiol (1981) 0.76
Conditioned place preferences, conditioned locomotion, and behavioral sensitization occur in rats treated with diethylpropion. Pharmacol Biochem Behav (1995) 0.76